Because of ethical considerations, scientists haven’t been able to conduct randomized controlled trials to conclusively prove the effectiveness of mask-wearing on interrupting coronavirus transmission ...
Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized ...
Acupuncture for preventing progression of taxane-induced peripheral neuropathy (ATP): A phase II randomized, placebo-controlled trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Management of nonalcoholic steatohepatitis (NASH) is an unmet clinical need. Lanifibranor is a pan-PPAR (peroxisome proliferator–activated receptor) agonist that modulates key metabolic, inflammatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results